We trade on the OTC Market under the symbol FORW.
Boulder City, NV, April 15, 2021 (GLOBE NEWSWIRE) -- George Sharp, President and CEO of Forwardly, Inc. (OTCMKT: FORW), announced today that the company has made a strategic investment in
Maverick Energy Group, Inc. (OTCMKT: MKGP).
The investment comes as a one year fixed rate convertible loan to Maverick in the amount of $200,000 at an APR of 15%. At Forwardly’s option, the principal and interest may convert into
Maverick common shares at $.20/share. The loan agreement also provides Forwardly with a warrant enabling the company to purchase up to two million additional shares of Maverick at
$.35/share within two years.
Note: On February 25, 2021 – HUMBLPay Inc. initiated a 4:1 Reverse Split in their common shares. The 500 million warrant shares that Forwardly, Inc held were reduced accordingly to 125
million warrant shares. The warrant shares are convertible at .20/share until December 2023.
Boulder City, NV, Dec. 10, 2020 (GLOBE NEWSWIRE) -- George Sharp, President and CEO of Forwardly, Inc. (OTCMKT: FORW), announced today that the company has made a cash investment
in Tesoro Enterprises, Inc. (OTCMKT: TSNP), soon to be renamed HUMBL, Inc., as one of two parties to purchase Tesoro warrants. These warrants enable Forwardly to purchase up to 500
million shares of Tesoro common stock within a period of two years. The agreement between Forwardly and Tesoro was entered into on November 23, 2020, and its closing was contingent on the
completion of the merger between HUMBL and Tesoro Enterprises, Inc., which has now taken place.
• a wholly owned subsidiary corporation
June 1, 2020 Forwardly, Inc. formed "Breathe
Medical Devices, Inc.", a wholly owned Wyoming corporation.
This subsidiary will be the operating arm for Forwardly's recent acquisition of the exclusive US distribution rights to LifeAir™, a patent pending,
non-invasive ventilator currently under development by Ligand Innovation Global, a Canadian
corporation. A newer iteration of the LifeAir ventilator is currently being engineered for a summer 2020 submission to the US Food and Drug Administration ("FDA") and Canada Health in the hopes
of obtaining fast track approval. A demonstration of a prototype of the LifeAir ventilator is available for viewing at www.LigandGlobal.com or www.BreatheMedicalDevices.com.
Management has an option to purchase up to 25% of Ligand Innovation Global following FDA approval of the ventilator.
The new subsidiary will at least initially be managed by Mr. Sharp, however, the company is currently reviewing the new asset with several prominent doctors and has
formed a Medical Advisory Board.
STOCK SYMBOL: OTC: FORW
“Forwardly is a public company seeking opportunities to partner in fresh ideas.”
Share Forwardly, Inc.:
3535 Executive Terminal Drive, Suite 110
Henderson, NV 89052